 - Intake of any drug or herbal preparation which, in the evaluation of the Investigator, may interfere with the clinical trial results by causing clinically relevant interference with glucose utilization, insulin action, or recovery from hypoglycemia eg, systemic corticosteroids, oral or inhaled glucocorticosteroids. 